In this week's PLoS Medicine, Augustine Choko of the Malawi-Liverpool Wellcome Trust Clinical Research Programme, Malawi and colleagues assess the uptake and accuracy of home-based supervised oral HIV self-testing in Malawi, ...
Oct 4, 2011
1
0
If your contact lenses are causing you discomfort, simply switching to a different type of contact lens or lens care product may bring improvement, reports a study, " Effect of Lens and Solution Choice on the Comfort of Contact ...
May 1, 2013
0
0
Researchers at the University of Eastern Finland have developed a cutting-edge deep learning model to predict the presence and to count various cell types in the tumor micro-environment. The multi-modal deep learning approach ...
Apr 17, 2023
0
35
Researchers with the SFU Nanodevice Fabrication Group are developing a new biosensor that can be used to screen for Alzheimer's disease and other diseases. An overview of their work has been recently published in the journal ...
Jan 18, 2023
0
79
Women who take extra vitamin D during their pregnancy are more likely to have a 'natural' delivery, according to University of Southampton research.
Feb 6, 2023
0
24
It may be impossible to avoid the current hype around Ozempic, a new weight-loss promoting drug that's so ubiquitous it ended up mentioned in Jimmy Kimmel's Oscar monolog.
Mar 22, 2023
0
15
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Oct 5, 2023
0
16
Patients who underwent endoscopic testing prior to surgery for lung cancer had significantly better quality of life at the end of the staging process, with no significant difference in costs between the two strategies, according ...
Jul 7, 2011
0
0
Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according ...
Sep 30, 2018
0
1
Last year a clinical trial of L-DOPA—a mainstay of Parkinson's disease therapy—was launched for Angelman syndrome, a rare intellectual disorder that shares similar motor symptoms such as tremors and difficulty with balance. ...
Nov 12, 2012
1
0
